News
StockStory.org on MSN4d
The 5 Most Interesting Analyst Questions From PacBio’s Q1 Earnings CallPacBio’s first quarter of 2025 was shaped by ongoing funding constraints in the academic and research sector, as well as ...
Pacific Biosciences of California (NASDAQ:PACB) ranks among the best CRISPR stocks to buy. Speaking on its strategic ...
Pacific Biosciences of California (PACB) closed the most recent trading day at $1.24, moving -3.88% from the previous trading ...
The NSC, led by Professor Kjetill S. Jakobsen and supported by Lab Manager Dr. Ave Tooming-Klunderud , is a leading center of ...
Ratings for Pacific Biosciences PACB +0.01% Get Free Report were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Paraphase – a computational tool that accurately resolves and analyzes paralogous genes – unlocks the difficult-to-analyze ...
Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results